Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort

Journal of the Neurological Sciences

Volumn 288, Issue 1-2, 2010, Pages 63-67

  Wu, Jing Shan ^a   Qiu, Wei ^a,e   Castley, Alison ^b   James, Ian ^c   Joseph, Joyce ^a   Christiansen, Frank T ^b,d   Carroll, William M ^a   Mastaglia, Frank L ^a   Kermode, Allan G ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

Australian; HLA DRB1; Multiple sclerosis; Oligoclonal bands

Indexed keywords

HLA DR ANTIGEN; OLIGOCLONAL BAND;

ADULT; ALLELE; ARTICLE; AUSTRALIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RACE DIFFERENCE; SWEDEN;

ADULT; ALLELES; AUSTRALIA; COHORT STUDIES; FEMALE; HLA-DR ANTIGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; RISK ASSESSMENT;

EID: 71249156005     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.10.005     Document Type: Article

References (24)

1. Villar L.M., Masterman T., Casanova B., et al. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis. J Neuroimmunol 211 1-2 (2009) 101-104
2. Andersson M., Alvarez-Cermeno J., Bernardi G., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57 8 (1994) 897-902
3. Link H., and Huang Y.M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180 1-2 (2006) 17-28
4. Owens G.P., Bennett J.L., Lassmann H., et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 65 6 (2009) 639-649
5. Lincoln M.R., Montpetit A., Cader M.Z., et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 37 10 (2005) 1108-1112
6. Hafler D.A., Compston A., Sawcer S., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357 9 (2007) 851-862
7. Sellebjerg F., Jensen J., Madsen H.O., et al. HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Tissue Antigens 55 4 (2000) 312-318
8. Imrell K., Landtblom A.M., Hillert J., et al. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67 6 (2006) 1062-1064
9. Kikuchi S., Fukazawa T., Niino M., et al. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 60 4 (2003) 647-651
10. Oksenberg J.R., Baranzini S.E., Sawcer S., et al. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9 7 (2008) 516-526
11. Barcellos L.F., Sawcer S., Ramsay P.P., et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15 18 (2006) 2813-2824
12. DeLuca G.C., Ramagopalan S.V., Herrera B.M., et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A 104 52 (2007) 20896-20901
13. Wu J.S., Zhang M.N., Carroll W.M., et al. Characterisation of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry 79 9 (2008) 1022-1026
14. Poser C.M., Paty D.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 13 3 (1983) 227-231
15. Compston A., Edan G., Goodkin D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 50 1 (2001) 121-127
16. Welborn T.A. The Besselton study: mapping population health. Cardiovascular and respiratory disease risk factors in Busselton, Australia (1998), Australasian Medical Publishing Company, Sydney
17. Sayer D., Whidborne R., Brestovac B., et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 57 1 (2001) 46-54
18. Walker R.W., Keir G., Johnson M.H., et al. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol 4 2 (1983) 141-148
19. Freedman M.S., Thompson E.J., Deisenhammer F., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62 6 (2005) 865-870
20. Stankovich J., Butzkueven H., Marriott M., et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens 74 1 (2009) 17-21
21. Wu J.S., Qiu W., Castley J.P., et al. Frequency of HLA-DRB1 alleles and disease-modifying effects in a large West Australian multiple sclerosis cohort. J Neurology 256 (2009) S158
22. Idiman E., Ozakbas S., Dogan Y., et al. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. J Neuroimmunol 212 1-2 (2009) 121-124
23. Obermeier B., Mentele R., Malotka J., et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 14 6 (2008) 688-693
24. Tintore M., Rovira A., Rio J., et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology 70 13 Pt 2 (2008) 1079-1083